About Homeobox protein TGIF1
Homeobox protein TGIF1 (TGIF1) is a protein
from Homo sapiens identified by UniProt accession
Q15583, 401 residues long.
MolForge cross-references it against 0 known binders and
164 disease associations.
Target properties
| Protein name | Homeobox protein TGIF1 |
| UniProt accession | Q15583 |
| Gene | TGIF1 |
| Organism | Homo sapiens |
| Length | 401 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (164)
Diseases linked to this target (Open Targets).
- holoprosencephaly · score 0.74
- neurodegenerative disease · score 0.53
- neutrophil count · score 0.42
- colorectal adenocarcinoma · score 0.41
- mean corpuscular volume · score 0.39
- alkaline phosphatase measurement · score 0.37
- midline interhemispheric variant of holoprosencephaly · score 0.37
- septopreoptic holoprosencephaly · score 0.37
- semilobar holoprosencephaly · score 0.37
- microform holoprosencephaly · score 0.37
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q15583-F1 | alphafold | PREDICTED | 58.10 | — |
Amino-acid sequence (401 residues)
MVLAQSRVSA GVGSPHCSGS GGGGSDSFPW PASHPGNPQC SFSTAFLASP RLSRGTLAYL PPAPWSSLAT PSALLGSSCA PPPPPARCPQ PRALSPELGT KAGPRRPHRW ELPRSPSQGA QGPAPRRRLL ETMKGIVAAS GSETEDEDSM DIPLDLSSSA GSGKRRRRGN LPKESVQILR DWLYEHRYNA YPSEQEKALL SQQTHLSTLQ VCNWFINARR RLLPDMLRKD GKDPNQFTIS RRGAKISETS SVESVMGIKN FMPALEETPF HSCTAGPNPT LGRPLSPKPS SPGSVLARPS VICHTTVTAL KDVPFSLCQS VGVGQNTDIQ QIAAKNFTDT SLMYPEDTCK SGPSTNTQSG LFNTPPPTPP DLNQDFSGFQ LLVDVALKRA AEMELQAKLT A
Explore Homeobox protein TGIF1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets